Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant
View ORCID ProfileGuilherme R. F. Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amormino Corsini, Sarah Vieira Contin Gomes, Daniel Alvim Pena de Miranda, Jéssica Vieira de Assis, Thaís Bárbara de Souza Silva, Pedro Augusto Alves, Gabriel da Rocha Fernandes, Jaquelline Germano de Oliveira, Paula Rahal, Rafaella Fortini Grenfelle Queiroz, Maurício L. Nogueira
doi: https://doi.org/10.1101/2022.03.24.22272904
Guilherme R. F. Campos
1Laboratório de Pesquisas em Virologia (LPV), Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo State, Brazil
Nathalie Bonatti Franco Almeida
2Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), Belo Horizonte, Minas Gerais, Brazil
Priscilla Soares Filgueiras
2Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), Belo Horizonte, Minas Gerais, Brazil
Camila Amormino Corsini
2Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), Belo Horizonte, Minas Gerais, Brazil
Sarah Vieira Contin Gomes
2Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), Belo Horizonte, Minas Gerais, Brazil
Daniel Alvim Pena de Miranda
2Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), Belo Horizonte, Minas Gerais, Brazil
Jéssica Vieira de Assis
2Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), Belo Horizonte, Minas Gerais, Brazil
Thaís Bárbara de Souza Silva
3Laboratório de Imunologia de Doenças Virais, Instituto Rene Rachou - Fundação Oswaldo Cruz
Pedro Augusto Alves
3Laboratório de Imunologia de Doenças Virais, Instituto Rene Rachou - Fundação Oswaldo Cruz
Gabriel da Rocha Fernandes
2Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), Belo Horizonte, Minas Gerais, Brazil
Jaquelline Germano de Oliveira
4Laboratório de Imunologia Celular e Molecular, instituto Rene Rachou - Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil
Paula Rahal
5Laboratório de Estudos Genômicos, Departamento de Biologia, Instituto de Biociências Letras e Ciências Exatas (IBILCE), Universidade Estadual Paulista (Unesp), São José do Rio Preto, Brazil
Rafaella Fortini Grenfelle Queiroz
2Diagnosis and Therapy of Infectious Diseases and Cancer, Oswaldo Cruz Foundation (Fiocruz), Belo Horizonte, Minas Gerais, Brazil
Maurício L. Nogueira
6Laboratório de Pesquisas em Virologia (LPV), Faculdade de Medicina de São José do Rio Preto (FAMERP), São Paulo State, Brazil; Hospital de Base, São José do Rio Preto, São Paulo State, Brazil; Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA
Data Availability
All data produced in the present work are contained in the manuscript
Posted March 25, 2022.
Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant
Guilherme R. F. Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amormino Corsini, Sarah Vieira Contin Gomes, Daniel Alvim Pena de Miranda, Jéssica Vieira de Assis, Thaís Bárbara de Souza Silva, Pedro Augusto Alves, Gabriel da Rocha Fernandes, Jaquelline Germano de Oliveira, Paula Rahal, Rafaella Fortini Grenfelle Queiroz, Maurício L. Nogueira
medRxiv 2022.03.24.22272904; doi: https://doi.org/10.1101/2022.03.24.22272904
Booster dose of BNT162b2 in a CoronaVac primary vaccination protocol improves neutralization of SARS-CoV-2 Omicron variant
Guilherme R. F. Campos, Nathalie Bonatti Franco Almeida, Priscilla Soares Filgueiras, Camila Amormino Corsini, Sarah Vieira Contin Gomes, Daniel Alvim Pena de Miranda, Jéssica Vieira de Assis, Thaís Bárbara de Souza Silva, Pedro Augusto Alves, Gabriel da Rocha Fernandes, Jaquelline Germano de Oliveira, Paula Rahal, Rafaella Fortini Grenfelle Queiroz, Maurício L. Nogueira
medRxiv 2022.03.24.22272904; doi: https://doi.org/10.1101/2022.03.24.22272904
Subject Area
Subject Areas
- Addiction Medicine (351)
- Allergy and Immunology (674)
- Anesthesia (181)
- Cardiovascular Medicine (2667)
- Dermatology (225)
- Emergency Medicine (404)
- Epidemiology (12284)
- Forensic Medicine (10)
- Gastroenterology (766)
- Genetic and Genomic Medicine (4134)
- Geriatric Medicine (387)
- Health Economics (682)
- Health Informatics (2681)
- Health Policy (1008)
- Hematology (365)
- HIV/AIDS (856)
- Medical Education (400)
- Medical Ethics (109)
- Nephrology (443)
- Neurology (3922)
- Nursing (212)
- Nutrition (583)
- Oncology (2057)
- Ophthalmology (592)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1122)
- Primary Care Research (458)
- Public and Global Health (6557)
- Radiology and Imaging (1411)
- Respiratory Medicine (874)
- Rheumatology (413)
- Sports Medicine (344)
- Surgery (454)
- Toxicology (54)
- Transplantation (188)
- Urology (167)